Actinium Pharmaceuticals

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$81
$0
Gross Profit
-189
-216
-118
-200
EBITDA
-12,229
-9,381
-10,144
-14,151
EBIT
-12,418
-9,597
-10,343
-14,351
Net Income
-11,353
-8,670
-9,324
-13,276
Net Change In Cash
0
0
81
0
Free Cash Flow
-7,972
-7,385
-7,490
-11,155
Cash
86,037
84,057
76,677
82,978
Basic Shares
30,103
27,886
27,634
27,058

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$81
$1,030
$1,144
$622
Gross Profit
-709
331
620
-447
EBITDA
-51,130
-33,405
-24,440
-21,946
EBIT
-51,920
-34,104
-24,964
-22,393
Net Income
-48,818
-31,930
-24,584
-22,037
Net Change In Cash
81
1,030
1,144
622
Cost of Revenue
14,222
54,306
Free Cash Flow
-47,488
8,278
-20,999
-21,870
Cash
76,677
108,910
77,829
63,560
Basic Shares
26,604
24,141
20,568
12,134

Earnings Calls

Quarter EPS
2024-06-30
-$0.38
2024-03-31
-$0.31
2023-12-31
-$0.34
2023-09-30
-$0.49